The FDA prohibits disease prevention or treatment claims for unapproved products, requiring cautious presentation of experimental interventions like the fasting-mimicking diet. — Whalespan
The FDA prohibits disease prevention or treatment claims for unapproved products, requiring cautious presentation of experimental interventions like the fasting-mimicking diet.
⚠ High risk
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
◐PARTIALLYSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“Now, the FDA prohibits any product or any claim related to disease prevention or treatment for something that has not been FDA-approved. So then, you know, I think an oncologist should be very careful in presenting it to the patient.”